Skip to main content

Molecular Genetics of Brain Noradrenergic Neurotransmission

  • Reference work entry
Handbook of Neurochemistry and Molecular Neurobiology
  • 1228 Accesses

Abstract:

The brain noradrenergic system plays a pivotal role in mediating the responses of the organism to the external and internal milieu and particularly to stress. The different components of this system have been implicated in a wide range of normal and pathological behavior. Recent advances in molecular psychiatric genetics may pave the way for a better understanding of the etiology of different symptoms of mental diseases and their relationship to environmental factors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AAD:

Aromatic Amino acid Decarboxylase

AC:

adenylyl cyclase

ADs:

antidepressant drugs

BMP:

Bone Morphogenetic Proteins

COMT:

catechol-O-methyltransferase

DAG:

diacylglycerol

DOPA:

3,4 dihydroxyphenylalanine

DHPG:

3,4-dihydroxyphenyl-glycol

MHPG:

3-methoxy-4-hydroxyphenylglycol

fmri:

functional magnetic resonance imaging

Gata3:

GATA-binding protein 3

GDP:

guanosine diphosphate

GPCRs:

G protein-coupled receptors

GTP:

guanosine triphosphate

HPA:

hypothalamic-pituitary-adrenal

LC:

Locus Coeruleus

MAOs:

monoamineoxidases

NET:

NE transporter

PKC:

protein kinase C

PKA:

protein kinases A

PNMT:

Phenylethanolamine-N-Methyl-Transferase

PLC:

phospholipase C

PTSD:

posttraumatic stress disorder

SSRIs:

selective serotonin reuptake inhibitors

TH:

Tyrosine Hydroxylase

VMA:

vanyl-mandelic acid

VCF:

velocardiofacial syndrome

VMAT:

vesicular monoamine transporter

References

  • Albanese V, Biguet NF, Kiefer H, Bayard E, Mallet, J, et al. 2001. Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. Hum Mol Genet 10: 1785–1792.

    Article  CAS  PubMed  Google Scholar 

  • Archer T. 1982. The role of noradrenaline in learned behaviors: Studies using DSP4. Scand J Psychol Suppl 1: 61–71.

    Article  Google Scholar 

  • Aston-Jones G, Cohen, JD. 2005. An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance. Annu Rev Neurosci 28: 403–450.

    Article  CAS  PubMed  Google Scholar 

  • Aston-Jones G, Rajkowski J, Cohen J. 1999. Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46: 1309–1320.

    Article  CAS  PubMed  Google Scholar 

  • Aston-Jones G, Rajkowski J, Kubiak P, Alexinsky T. 1994. Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task. J Neurosci 14: 4467–4480.

    CAS  PubMed  Google Scholar 

  • Beaulieu J-M, Sotnikova TD, Yao W.-D, Kockeritz L, Woodgett JR, et al. 2004. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 101: 5099–5104.

    Article  CAS  PubMed  Google Scholar 

  • Benjamin J, Osher Y, Kotler M, Gritsenko I, Nemanov L, et al. 2000. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: Dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol-O-methyltransferase (COMT). Mol Psychiatry 5: 96–100.

    Article  CAS  PubMed  Google Scholar 

  • Berridge M. 1993. Cell signalling. A tale of two messengers. Nature 365: 388–389.

    Article  CAS  PubMed  Google Scholar 

  • Berridge CW, Waterhouse BD. 2003. The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 42: 33–84.

    Article  PubMed  Google Scholar 

  • Bertocci B, Miggiano V, Da Prada M, Dembic Z, Lahm, HW, et al. 1991. Human catechol-O-methyltransferase: Cloning and expression of the membrane-associated form. Proc Natl Acad Sci USA 88: 1416–1420.

    Article  CAS  PubMed  Google Scholar 

  • Boehm S, Kubista, H. 2002. Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 54: 43–99.

    Article  CAS  PubMed  Google Scholar 

  • Bray N, Buckland P, Williams N, Williams H, Norton N, et al. 2003. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73: 152–161.

    Article  CAS  PubMed  Google Scholar 

  • Brinkmann B, Sajantila A, Goedde H, Matsumoto H, Nishi K, et al. 1996. Population genetic comparisons among eight populations using allele frequency and sequence data from three microsatellite loci. Eur J Hum Genet 4: 175–182.

    CAS  PubMed  Google Scholar 

  • Brunet J-F, Pattyn A. 2002. Phox2 genes—from patterning to connectivity. Curr Opin Genet Dev 12: 435–440.

    Article  CAS  PubMed  Google Scholar 

  • Brunner HG, Nelen M, Breakfield XO, Ropers HH, Van Oost B. 1993. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262: 578–580.

    Article  CAS  PubMed  Google Scholar 

  • Burgert E, Crocq MA, Bausch E, Macher JP, Morris-Rosendahl DJ. 1998. No association between the tyrosine hydroxylase microsatellite marker HUMTH01 and schizophrenia or bipolar I disorder. Psychiatr Genet 8: 45–48.

    Article  CAS  PubMed  Google Scholar 

  • Byerley W, Plaetke R, Hoff M, Jensen S, Holik J, et al. 1992. Tyrosine hydroxylase gene not linked to manic-depression in seven of eight pedigrees. Hum Hered 42: 259–263.

    Article  CAS  PubMed  Google Scholar 

  • Bylund D. 1992. Subtypes of alpha 1- and alpha 2-adrenergic receptors. FASEB J 6: 832–839.

    CAS  PubMed  Google Scholar 

  • Bylund, DB. 2005. Alpha-2 adrenoceptor subtypes: Are more better? 144: 159-160.

    Google Scholar 

  • Bylund D, Eikenberg D, Hieble J, Langer S, Lefkowitz R, et al. 1994. International union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46: 121–136.

    CAS  PubMed  Google Scholar 

  • Cases O, Self I, Grimsby J, Gaspar P, Chen K, et al. 1995. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268: 1763–1766.

    Article  CAS  PubMed  Google Scholar 

  • Caspi A, McClay J, Moffitt TE, Mill J, Martin J, et al. 2002. Role of genotype in the cycle of violence in maltreated children. Science 297: 851–854.

    Article  CAS  PubMed  Google Scholar 

  • Cavazzoni P, Alda M, Turecki G, Rouleau G, Grof E, et al. 1996. Lithium-responsive affective disorders: No association with the tyrosine hydroxylase gene. Psychiatry Res 64: 91–96.

    Article  CAS  PubMed  Google Scholar 

  • de Chaldee M, Laurent C, Thibaut F, Martinez M, Samolyk D, et al. 1999. Linkage disequilibrium on the COMT gene in French schizophrenics and controls. Am J Med Genet 88: 452–457.

    Article  CAS  PubMed  Google Scholar 

  • Chen CH, Lee YR, Wei FC, Koong FJ, Hwu HG, et al. 1997. Association study of NlaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia. Biol Psychiatry 41: 985–987.

    Article  CAS  PubMed  Google Scholar 

  • Chiba M, Suzuki S, Hinokio Y, Hirai M, Satoh Y, et al. 2000. Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism 49: 1145–1149.

    Article  CAS  PubMed  Google Scholar 

  • Craddock N, Spurlock G, McGuffin P, Owen MJ, Nosten- Bertrand M, et al. 1997. No association between bipolar disorder and alleles at a functional polymorphism in the COMT gene. Br J Psychiatry 170: 526–528.

    Article  Google Scholar 

  • Craig SP, Buckle VJ, Lamouroux A, Mallet J, Craig IW. 1988. Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet 48: 48–50.

    Article  CAS  PubMed  Google Scholar 

  • Croager EJ, Gout AM, Abraham LJ. 2000. Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene. Am J Pathol 156: 1723–1731.

    CAS  PubMed  Google Scholar 

  • Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, et al. 1998. Dopamine beta-hydroxylase: Two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 102: 533–540.

    Article  CAS  PubMed  Google Scholar 

  • Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, et al. 1997. Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet 74: 374–379.

    Article  CAS  PubMed  Google Scholar 

  • Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, et al. 2000. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 5: 56–63.

    Article  CAS  PubMed  Google Scholar 

  • Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 4: 192–196.

    Article  CAS  PubMed  Google Scholar 

  • Daniels JK, Williams NM, Williams J, Jones LA, Cardno AG, et al. 1996. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-O-methyltransferase activity. Am J Psychiatry 153: 268–270.

    CAS  PubMed  Google Scholar 

  • De Benedictis G, Carotenuto L, Carrieri G, De Luca M, Falcone E, et al. 1998. Gene/longevity association studies at four autosomal loci (REN, THO, PARP, SOD2). Eur J Hum Genet 6: 534–541.

    Article  CAS  PubMed  Google Scholar 

  • Deckert J, Catalano M, Syagailo Y, Bosi M, Okladnova O, et al. 1999. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8: 621–624.

    Article  CAS  PubMed  Google Scholar 

  • Deinum J, Steenbergen-Spanjers GCH, Jansen M, Boomsma F, Lenders JWM, et al. 2004. DBH gene variants that cause low plasma dopamine {beta} hydroxylase with or without a severe orthostatic syndrome. J Med Genet 41: e38.

    Article  CAS  PubMed  Google Scholar 

  • Detera-Wadleigh S, Berrettini W, Goldin L, Boorman D, Anderson S, et al. 1987. Close linkage of c-Harvey-ras-1 and the insulin gene to affective disorder is ruled out in three North American pedigrees. Nature 325: 806–808.

    Article  CAS  PubMed  Google Scholar 

  • Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, et al. 2001. Effect of COMT val108/158 met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917–6922.

    Article  CAS  PubMed  Google Scholar 

  • Egeland JA, Gerhard DS, Pauls DL, Sussex JN, Kidd KK, et al. 1987. Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 325: 783–787.

    Article  CAS  PubMed  Google Scholar 

  • Eisenhofer G, Kopin IJ, Goldstein DS. 2004. Catecholamine metabolism: A contemporary view with implications for physiology and medicine. Pharmacol Rev 56: 331–349.

    Article  CAS  PubMed  Google Scholar 

  • Fan J-B, Yang M-S, Tang J-X, He L, Xing YL, et al. 2004. Family-based association study of the functional monoamine oxidase a gene promoter polymorphism and schizophrenia. Schizophr Res 67: 107–109.

    Article  PubMed  Google Scholar 

  • Ferguson SSG. 2001. Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitization and signaling. Pharmacol Rev 53: 1–24.

    CAS  PubMed  Google Scholar 

  • Ferguson J, Wesnes K, Schwartz G. 2003. Reboxetine versus paroxetine versus placebo: Effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol 18: 9–14.

    Article  PubMed  Google Scholar 

  • Fields TA, Casey PJ. 1997. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J 321: 561–571.

    CAS  PubMed  Google Scholar 

  • Foley DL, Eaves LJ, Wormley B, Silberg JL, Maes HH, et al. 2004. Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry 61: 738–744.

    Article  CAS  PubMed  Google Scholar 

  • Fuller R, Hemrick-Luecke S, Littlefield E, Audia J. 1995. Comparison of desmethylsertraline with sertraline as a monoamine uptake inhibitor in vivo. Prog Neuropsychopharmacol Biol Psychiatry 19: 135–149.

    Article  CAS  PubMed  Google Scholar 

  • Furlong RA, Rubinsztein JS, Ho L, Walsh C, Coleman TA, et al. 1999. Analysis and metaanalysis of two polymorphisms within the tyrosine hydroxylase gene in bipolar and unipolar affective disorders. Am J Med Genet 88: 88–94.

    Article  CAS  PubMed  Google Scholar 

  • Gallinat J, Bajbouj M, Sander T, Schlattmann P, Xu K, et al. 2003. Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 54: 40–48.

    Article  CAS  PubMed  Google Scholar 

  • Garland EM, Hahn MK, Ketch TP, Keller NR, Kim CH, et al. 2002. Genetic Basis of clinical catecholamine disorders. Ann NY Acad Sci 971: 506–514.

    Article  CAS  PubMed  Google Scholar 

  • Geller B, Cook Jr., EH. 2000. Ultradian rapid cycling in prepubertal and early adolescent bipolarity is not in transmission disequilibrium with val/met COMT alleles. Biol Psychiatry 47: 605–609.

    Article  CAS  PubMed  Google Scholar 

  • Gerhard D, LaBuda M, Bland S, Allen C, Egeland J, et al. 1994. Initial report of a genome search for the affective disorder predisposition gene in the old order amish pedigrees: Chromosomes 1 and 11. Am J Med Genet 54: 398–404.

    Article  CAS  PubMed  Google Scholar 

  • Gershon E, Goldin L, Badner J, Berrettini W. 1996. Detection of linkage to affective disorders in the catalogued amish pedigrees: A reply to Pauls et al. Am J Hum Genet 58: 1381–1385.

    CAS  PubMed  Google Scholar 

  • Gether U. 2000. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21: 90–113.

    Article  CAS  PubMed  Google Scholar 

  • Gill M, Castle D, Hunt N, Clements A, Sham P, et al. 1991. Tyrosine hydroxylase polymorphisms and bipolar affective disorder. J Psychiatr Res 25: 179–184.

    Article  CAS  PubMed  Google Scholar 

  • Ginns E, Egeland J, Allen C, Pauls D, Falls K, et al. 1992. Update on the search for DNA markers linked to manic-depressive illness in the old order amish. J Psychiatr Res 26: 305–308.

    Article  CAS  PubMed  Google Scholar 

  • Ginns E, Ott J, Egeland J, Allen C, Fann C, et al. 1996. A genome-wide search for chromosomal loci linked to bipolar affective disorder in the old order amish. Nat Genet 12: 431–435.

    Article  CAS  PubMed  Google Scholar 

  • Goridis C, Rohrer H. 2002. Specification of catecholaminergic and serotonergic neurons. Nat Rev Neurosci 3: 531–541.

    Article  CAS  PubMed  Google Scholar 

  • Grace AA. 1991. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience 41: 1–24.

    Article  CAS  PubMed  Google Scholar 

  • Grace AA. 1993. Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm Gen Sect 91: 111–134.

    Article  CAS  PubMed  Google Scholar 

  • Grossman MH, Emanuel BS, Budarf ML. 1992. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1–q11.2. Genomics 12: 822–825.

    Article  CAS  PubMed  Google Scholar 

  • Gurling H, Smyth C, Kalsi G, Moloney E, Rifkin L, et al. 1995. Linkage findings in bipolar disorder. Nat Genet 10: 8–9.

    Article  CAS  PubMed  Google Scholar 

  • Gutierrez B, Bertranpetit J, Guillamat R, Valles V, Arranz MJ, et al. 1997. Association analysis of the catechol-O-methyltransferase gene and bipolar affective disorder. Am J Psychiatry 154: 113–115.

    CAS  PubMed  Google Scholar 

  • HamiltonS, Slager S, Heiman G, Haghighi F, Klein D, et al. 2000. No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder. Mol Psychiatry 5: 465–466.

    Article  CAS  PubMed  Google Scholar 

  • Hawi Z, Lowe N, Kirley A, Gruenhage F, Nothen M, et al. 2003. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 8: 299–308.

    Article  CAS  PubMed  Google Scholar 

  • Hoda F, Nicholl D, Bennett P, Arranz M, Aitchison KJ, et al. 1996. No association between Parkinson's disease and low-activity alleles of catechol-O-methyltransferase. Biochem Biophys Res Commun 228: 780–784.

    Article  CAS  PubMed  Google Scholar 

  • Hodgkinson S, Sherrington R, Gurling H, Marchbanks R, Reeders S, et al. 1987. Molecular genetic evidence for heterogeneity in manic depression. Nature 325: 805–806.

    Article  CAS  PubMed  Google Scholar 

  • Houhou L, Lamouroux A, Faucon Biguet N, Mallet J. 1995. Expression of human dopamine β-hydroxylase in mammalian cells infected by recombinant vaccinia virus. J Biol Chem 270: 12601–12606.

    Article  CAS  PubMed  Google Scholar 

  • Huang Y, Cate S, Battistuzzi C, Oquendo M, Brent D, et al. 2004. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology 29: 1498–1505.

    Article  CAS  PubMed  Google Scholar 

  • Hubbard KB, Hepler JR. 2006. Cell signalling diversity of the Gq[alpha] family of heterotrimeric G proteins. Cellular Signalling 18: 135–150.

    Article  CAS  PubMed  Google Scholar 

  • Ibanez A, Perez de Castro I, Fernandez-Piqueras J, Blanco C, Saiz-Ruiz J. 2000. Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. Mol Psychiatry 5: 105–109.

    Article  CAS  PubMed  Google Scholar 

  • Icard Liepkalns C, Faucon Biguet N, Vyas S, Robert JJ, Sassone Corsi P, et al. 1992. AP-1 complex and c-fos transcription are involved in TPA provoked and trans-synaptic inductions of the tyrosine hydroxylase gene: Insights into long-term regulatory mechanisms. J Neurosci Res 32: 290–298.

    Article  CAS  PubMed  Google Scholar 

  • Inayama Y, Yoneda H, Sakai T, Ishida T, Kobayashi S, et al. 1993. Lack of association between bipolar affective disorder and tyrosine hydroxylase DNA marker. Am J Med Genet 48: 87–89.

    Article  CAS  PubMed  Google Scholar 

  • Ishii A, Kobayashi K, Kiuchi K, Nagatsu T. 1991. Expression of two forms of human dopamine-beta-hydroxylase in COS cells. Neurosci Lett 125: 25–28.

    Article  CAS  PubMed  Google Scholar 

  • Jindra A, Jachymova M, Horky K, Peleska J, Umnerova V, et al. 2000. Association analysis of two tyrosine hydroxylase gene polymorphisms in normotensive offspring from hypertensive families. Blood Press 9: 250–254.

    Article  CAS  PubMed  Google Scholar 

  • Jönsson EG, Bah J, Melke J, Jamra RA, Schumacher J, et al. 2004. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers. BMC Psychiatry 4: 4.

    Article  PubMed  Google Scholar 

  • Jonsson EG, Geijer T, Gyllander A, Terenius L, Sedvall GC. 1998. Failure to replicate an association between a rare allele of a tyrosine hydroxylase gene microsatellite and schizophrenia. Eur Arch Psychiatry Clin Neurosci 248: 61–63.

    Article  CAS  PubMed  Google Scholar 

  • Jonsson EG, Norton N, Forslund K, Mattila-Evenden M, Rylander G, et al. 2003. Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophr Res 61: 31–37.

    Article  PubMed  Google Scholar 

  • Jonsson E, Sedvall G, Brene S, Gustavsson JP, Geijer T, et al. 1996. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry 40: 1032–1043.

    Article  CAS  PubMed  Google Scholar 

  • Jorm A, Henderson A, Jacomb P, Christensen H, Korten A, et al. 2000. Association of a functional polymorphism of the monoamine oxidase A gene promoter with personality and psychiatric symptoms. Psychiatr Genet 10: 87–90.

    Article  CAS  PubMed  Google Scholar 

  • Kang J, Shi Y, Xiang B, Qu B, Su W, et al. 2005. A nuclear function of [beta]-arrestin1 in GPCR signaling: Regulation of histone acetylation and gene transcription. Cell 123: 833–847.

    Article  CAS  PubMed  Google Scholar 

  • Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, et al. 1997. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94: 4572–4575.

    Article  CAS  PubMed  Google Scholar 

  • Karayiorgou M, Gogos J. 1997. A turning point in schizophrenia genetics. Neuron 19: 967–979.

    Article  CAS  PubMed  Google Scholar 

  • Karayiorgou M, Gogos JA, Galke BL, Wolyniec PS, Nestadt G, et al. 1998. Identification of sequence variants and analysis of the role of the catechol-O-methyl-transferase gene in schizophrenia susceptibility. Biolo Psychiatry 43: 425–431.

    Article  CAS  Google Scholar 

  • Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, et al. 1995. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 92: 7612–7616.

    Article  CAS  PubMed  Google Scholar 

  • Kawada Y, Hattori M, Fukuda R, Arai H, Inoue R, et al. 1995. No evidence of linkage or association between tyrosine hydroxylase gene and affective disorder. J Affect Disord 34: 89–94.

    Article  CAS  PubMed  Google Scholar 

  • Kelsoe J, Ginns E, Egeland J, Gerhard D, Goldstein A, et al. 1989. Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the old order amish. Nature 342: 238–243.

    Article  CAS  PubMed  Google Scholar 

  • Kirov G, Norton N, Jones I, McCandless F, Craddock N, et al. 1999. A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder. Int J Neuropsychopharmcol 2: 293–298.

    Article  CAS  Google Scholar 

  • Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, et al. 1997. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 17: 8451–8458.

    CAS  PubMed  Google Scholar 

  • Kohnke MD, Zabetian CP, Anderson GM, Kolb W, Gaertner I, et al. 2002. A genotype-controlled analysis of plasma dopamine [beta]-hydroxylase in healthy and alcoholic subjects: Evidence for alcohol-related differences in noradrenergic function. Biol Psychiatry 52: 1151–1158.

    Article  CAS  PubMed  Google Scholar 

  • Korner J, Fritze J, Propping P. 1990. RFLP alleles at the tyrosine hydroxylase locus: No association found to affective disorders. Psychiatry Res 32: 275–280.

    Article  CAS  PubMed  Google Scholar 

  • Korner J, Rietschel M, Hunt N, Castle D, Gill M, et al. 1994. Association and haplotype analysis at the tyrosine hydroxylase locus in a combined German–British sample of manic depressive patients and controls. Psychiatr Genet 4: 167–175.

    Article  CAS  PubMed  Google Scholar 

  • Kunugi H, Ishida S, Kato T, Tatsumi M, Sakai T, et al. 1999. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry 4: 393–395.

    Article  CAS  PubMed  Google Scholar 

  • Kunugi H, Nanko S, Ueki A, Otsuka E, Hattori M, et al. 1997a. High and low activity alleles of catechol-O-methyltransferase gene: Ethnic difference and possible association with Parkinson's disease. Neurosci Lett 221: 202–204.

    Article  CAS  Google Scholar 

  • Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, et al. 1997b. No evidence for an association of affective disorders with high- or low-activity allele of catechol-O-methyltransferase gene. Biol Psychiatry 42: 282–285.

    Article  CAS  Google Scholar 

  • Kurumaji A, Kuroda T, Yamada K, Yoshikawa T, Toru M. 2001. An association of the polymorphic repeat of tetranucleotide (TCAT) in the first intron of the human tyrosine hydroxylase gene with schizophrenia in a Japanese sample. J Neural Transm 108: 489–495.

    Article  CAS  PubMed  Google Scholar 

  • Lachman HM, Kelsoe J, Moreno L, Katz S, Papolos DF. 1997. Lack of association of catechol-O-methyltransferase (COMT) functional polymorphism in bipolar affective disorder. Psychiatric Genet 7: 13–17.

    Article  CAS  Google Scholar 

  • Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, et al. 1996b. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 67: 468–472.

    Article  CAS  Google Scholar 

  • Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J. 1998. Association between catechol-O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 155: 835–837.

    CAS  PubMed  Google Scholar 

  • Lachman HM, Papolos DF, Saito T, Yu Y-M, Szumlanski CL, et al. 1996a. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6: 243–250.

    Article  CAS  Google Scholar 

  • Lan NC, Heinzmann C, Gal A, Klisak I, Orth U, et al. 1989. Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with norrie disease. Genomics 4: 552–559.

    Article  CAS  PubMed  Google Scholar 

  • Leboyer M, Malafosse A, Boularand S, Campion D, Gheysen F, et al. 1990. Tyrosine hydroxylase polymorphisms associated with manic-depressive illness. Lancet 335: 1219.

    Article  CAS  PubMed  Google Scholar 

  • Leonard B. 2001. Stress, norepinephrine and depression. J Psychiatry Neurosci 26: Suppl: S11–S16.

    PubMed  Google Scholar 

  • Lester HA, Cao Y, Mager S. 1996. Listening to neurotransmitter transporters. Neuron 17: 807–810.

    Article  CAS  PubMed  Google Scholar 

  • Li T, Vallada H, Curtis D, Arranz M, Xu K, et al. 1997. Catechol-O-methyltransferase Val158Met polymorphism: Frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics 7: 349–353.

    Article  CAS  PubMed  Google Scholar 

  • Lim LC, Gurling H, Curtis D, Brynjolfsson J, Petursson H, et al. 1993. Linkage between tyrosine hydroxylase gene and affective disorder cannot be excluded in two of six pedigrees. Am J Med Genet 48: 223–228.

    Article  CAS  PubMed  Google Scholar 

  • Lobos EA, Todd RD. 1997. Cladistic analysis of disease association with tyrosine hydroxylase: Application to manic-depressive disease and alcoholism. Am J Med Genet 74: 289–295.

    Article  CAS  PubMed  Google Scholar 

  • Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177–182.

    Article  CAS  PubMed  Google Scholar 

  • Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, et al. 1995. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34: 4202–4210.

    Article  CAS  PubMed  Google Scholar 

  • Lundstrom K, Tenhunen J, Tilgmann C, Karhunen T, Panula P, et al. 1995. Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta Protein Structure and Molecular Enzymology 1251: 1–10.

    Article  CAS  Google Scholar 

  • Malafosse A, Leboyer M, d'Amato T, Amadeo S, Abbar M, et al. 1997. Manic depressive illness and tyrosine hydroxylase gene: Linkage heterogeneity and association. Neurobiol Dis 4: 337–349.

    Article  CAS  PubMed  Google Scholar 

  • Mallet J. 1996. The TiPS/TINS lecture. Catecholamines: From gene regulation to neuropsychiatric disorders. Trends Pharmacol Sci 17: 129–135.

    Article  CAS  PubMed  Google Scholar 

  • Mandela P, Ordway GA. 2006. The norepinephrine transporter and its regulation. J Neurochem 97: 310–333.

    Article  CAS  PubMed  Google Scholar 

  • Masson J, Sagne C, Hamon M, Mestikawy SE. 1999. Neurotransmitter transporters in the central nervous system. Pharmacol Rev 51: 439–464.

    CAS  PubMed  Google Scholar 

  • Mattay VS, Goldberg TE., Fera F, Hariri AR., Tessitore A, et al. 2003. Catechol-O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186–6191.

    Article  CAS  PubMed  Google Scholar 

  • Melia K, Duman R. 1991. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci USA 88: 8382–8386.

    Article  CAS  PubMed  Google Scholar 

  • Melia K, Rasmussen K, Terwilliger R, Haycock J, Nestler E, et al. 1992. Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: Effects of chronic stress and drug treatments. J Neurochem 58: 494–502.

    Article  CAS  PubMed  Google Scholar 

  • Meloni R, Albanese V, Ravassard P, Treilhou F, Mallet J. 1998. A tetranucleotide polymorphic microsatellite, located in the first intron of the tyrosine hydroxylase gene, acts as a transcription regulatory element in vitro. Hum Mol Genet 7: 423–428.

    Article  CAS  PubMed  Google Scholar 

  • Meloni R, Laurent C, Campion D, Ben Hadjali B, Thibaut F, et al. 1995b. A rare allele of a microsatellite located in the tyrosine hydroxylase gene found in schizophrenic patients. C R Acad Sci III 318: 803–809.

    CAS  Google Scholar 

  • Meloni R, Leboyer M, Bellivier F, Barbe B, Samolyk D, et al. 1995a. Association of manic-depressive illness with tyrosine hydroxylase microsatellite marker. Lancet 345: 932.

    Article  CAS  Google Scholar 

  • Meyer E, Wiegand P, Rand SP, Kuhlmann D, Brack M, et al. 1995. Microsatellite polymorphisms reveal phylogenetic relationships in primates. J Mol Evol 41: 10–14.

    Article  CAS  PubMed  Google Scholar 

  • Moore H, West AR, Grace AA. 1999. The regulation of forebrain dopamine transmission: Relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry 46: 40–55.

    Article  CAS  PubMed  Google Scholar 

  • Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, et al. 2005. Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry—Experimental Stress: From Basic to Clinical Aspects 29: 1214–1224.

    CAS  Google Scholar 

  • Müller Smith K, Daly M, Fischer M, Yiannoutsos CT, Bauer L, et al. 2003. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: Genetic analysis of the Milwaukee longitudinal study. Am J Med Genet 119B: 77–85.

    Article  Google Scholar 

  • Mynett-Johnson LA, Murphy VE, Claffey E, Shields DC, McKeon P. 1998. Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr Genet 8: 221–225.

    Article  CAS  PubMed  Google Scholar 

  • Neer EJ. 1995. Heterotrimeric C proteins: Organizers of transmembrane signals. Cell 80: 249–257.

    Article  CAS  PubMed  Google Scholar 

  • Nelson JC. 1999. A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression. Biol Psychiatry 46: 1301–1308.

    Article  CAS  PubMed  Google Scholar 

  • Njus D, Kelley P, Harnadek G. 1986. Bioenergetics of secretory vesicles. Biochim Biophys Acta 853: 237–265.

    CAS  PubMed  Google Scholar 

  • Ohmori O, Shinkai T, Kojima H, Terao T, Suzuki T, et al. 1998. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neurosci Lett 243: 109–112.

    Article  CAS  PubMed  Google Scholar 

  • Ordway G. 1997. Pathophysiology of the locus coeruleus in suicide. Ann N Y Acad Sci 836: 233–252.

    Article  CAS  PubMed  Google Scholar 

  • Pakstis A, Kidd J, Castiglione C, Kidd K. 1991. Status of the search for a major genetic locus for affective disorder in the old order amish. Hum Genet 87: 475–483.

    Article  CAS  PubMed  Google Scholar 

  • Palmatier MA, Kang AM, Kidd KK. 1999. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46: 557–567.

    Article  CAS  PubMed  Google Scholar 

  • Perez de Castro I, Santos J, Torres P, Visedo G, Saiz-Ruiz J, et al. 1995. A weak association between TH and DRD2 genes and bipolar affective disorder in a Spanish sample. J Med Genet 32: 131–134.

    Article  CAS  PubMed  Google Scholar 

  • Persson ML, Wasserman D, Jonsson EG, Bergman H, Terenius L, et al. 2000. Search for the influence of the tyrosine hydroxylase (TCAT)(n) repeat polymorphism on personality traits. Psychiatry Res 95: 1–8.

    Article  CAS  PubMed  Google Scholar 

  • Polymeropoulos M, Xiao H, Rath D, Merril C. 1991. Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). Nucleic Acids Res 19: 3753.

    Google Scholar 

  • de Pontual L, Nepote V, Attie-Bitach T, Al Halabiah H, Trang H, et al. 2003. Noradrenergic neuronal development is impaired by mutation of the proneural HASH-1 gene in congenital central hypoventilation syndrome (ondine's curse). Hum Mol Genet 12: 3173–3180.

    Article  CAS  PubMed  Google Scholar 

  • Puers C, Hammond HA, Jin L, Caskey T, Schumm JW. 1993. Identification of repeat sequence heterogeneity at the polymorphic short tandem repeat locus HUMTH01 (AATG)n and reassignment of alleles in population analysis by using a locus-specific allelic ladder. Am J Hum Genet 53: 953–958.

    CAS  PubMed  Google Scholar 

  • Pulver AE, Karayiorgou M, Lasseter VK, Wolyniec P, Kasch L, et al. 1994b. Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12–q13.1: Part 2. Am J Med Genet 54: 44–50.

    Article  CAS  Google Scholar 

  • Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, et al. 1994a. Sequential strategy to identify a susceptibility gene for schizophrenia: Report of potential linkage on chromosome 22q12–q13.1: Part 1. Am J Med Genet 54: 36–43.

    Article  CAS  Google Scholar 

  • Sabban EL, Kvetnansky R. 2001. Stress-triggered activation of gene expression in catecholaminergic systems: Dynamics of transcriptional events. Trends Neurosci 24: 91–98.

    Article  CAS  PubMed  Google Scholar 

  • Sabol S, Hu S, Hamer D. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103: 273–279.

    Article  CAS  PubMed  Google Scholar 

  • Sander T, Harms H, Rommelspacher H, Hoehe M, Schmidt LG. 1998. Possible allelic association of a tyrosine hydroxylase polymorphism with vulnerability to alcohol-withdrawal delirium. Psychiatr Genet 8: 13–17.

    Article  CAS  PubMed  Google Scholar 

  • Sassone-Corsi P, Lamph WW, Kamps M, Verma IM. 1988. Fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell 54: 553–560.

    Article  CAS  PubMed  Google Scholar 

  • Schatzberg A. 2000. Clinical efficacy of reboxetine in major depression. J Clin Psychiatry 61: 31–38.

    CAS  PubMed  Google Scholar 

  • Schildkraut JJ. 1965. The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 122: 509–522.

    CAS  PubMed  Google Scholar 

  • Schultz, W, Dayan P, Montague P. 1997. A neural substrate of prediction and reward. Science 275: 1593–1599.

    Article  CAS  PubMed  Google Scholar 

  • Schulze T, Muller D, Krauss H, Scherk H, Ohlraun S, et al. 2000. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 96: 801–803.

    Article  CAS  PubMed  Google Scholar 

  • SerrettiA, Macciardi F, Cusin C, Verga M, Pedrini S, 1998a. Tyrosine hydroxylase gene in linkage disequilibrium with mood disorders. Mol Psychiatry 3: 169–174.

    Article  CAS  Google Scholar 

  • Serretti A, Macciardi F, Verga M, Cusin C, Pedrini S, et al. 1998b. Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder. Am J Med Genet 81: 127–130.

    Article  CAS  Google Scholar 

  • Servan-Schreiber D, Printz H, Cohen J. 1990. A network model of catecholamine effects: Gain, signal-to-noise ratio, and behavior. Science 249: 892–895.

    Article  CAS  PubMed  Google Scholar 

  • Shifman S, Bronstein M, Sternfeld M, Pisanté A, Weizman A, et al. 2004. COMT: A common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet 128B: 61–64.

    Article  PubMed  Google Scholar 

  • Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, et al. 2003. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71: 1296–1302.

    Article  Google Scholar 

  • Shih JC, Chen K, Ridd, J. 1999. Monoamine oxidase: From genes to behavior. Annu Rev Neurosci 22: 197–217.

    Article  CAS  PubMed  Google Scholar 

  • Smyth C, Kalsi G, Brynjolfsson J, O'Neill J, Curtis D, et al. 1996. Further tests for linkage of bipolar affective disorder to the tyrosine hydroxylase gene locus on chromosome 11p15 in a new series of multiplex British affective disorder pedigrees. Am J Psychiatry 153: 271–274.

    CAS  PubMed  Google Scholar 

  • Souery D, Lipp O, Mahieu B, Mendelbaum K, De Martelaer V, et al. 1996. Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes. Am J Med Genet 67: 551–555.

    Article  CAS  PubMed  Google Scholar 

  • Souery D, Lipp O, Rivelli SK, Massat I, Serretti A, et al. 1999. Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: A multicenter association study. Am J Med Genet 88: 527–532.

    Article  CAS  PubMed  Google Scholar 

  • Southwick S, Yehuda R, Giller EJ. 1993. Personality disorders in treatment-seeking combat veterans with posttraumatic stress disorder. Am J Psychiatry 150: 1020–1023.

    CAS  PubMed  Google Scholar 

  • Starke K. 2001. Presynaptic autoreceptors in the third decade: Focus on alpha2-adrenoceptors. J Neurochem 78: 685–693.

    Article  CAS  PubMed  Google Scholar 

  • Stolk JM, Hurst JH, Nisula BC. 1982. Regulation and inheritance of dopamine-beta-hydroxylase. Behav Genet 12: 37–52.

    Article  CAS  PubMed  Google Scholar 

  • Strous RD, Bark N, Woerner M, Lachman HM. 1997. Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 41: 493–495.

    Article  CAS  PubMed  Google Scholar 

  • Sugama S, Namihira T, Matsuoka R, Taira N, Eto Y, et al. 1999. Psychiatric inpatients and chromosome deletions within 22q11.2. J Neurol Neurosurg Psychiatry 67: 803–806.

    Article  CAS  PubMed  Google Scholar 

  • Sullivan G, Coplan J, Kent J, Gorman J. 1999. The noradrenergic system in pathological anxiety: A focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry 46: 1205–1218.

    Article  CAS  PubMed  Google Scholar 

  • Syagailo Y, Stober G, Grassle M, Reimer E, Knapp M, et al. 2001. Association analysis of the functional monoamine oxidase a gene promoter polymorphism in psychiatric disorders. Am J Med Genet 105: 168–171.

    Article  CAS  PubMed  Google Scholar 

  • Syvanen A-C, Tilgmann C, Rinne J, Ulmanen I. 1997. Genetic polymorphism of catechol-O-methyltransferase (COMT): Correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland. Pharmacogenetics 7: 65–71.

    Article  CAS  PubMed  Google Scholar 

  • Taussig R, Gilman AG. 1995. Mammalian membrane-bound adenylyl cyclases. J Biol Chem 270: 1–4.

    Article  CAS  PubMed  Google Scholar 

  • Tenhunen J, Salminen M, Lundstrom K, Savolainen R, Ulmanen I. 1994. Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223: 1049–1059.

    Article  CAS  PubMed  Google Scholar 

  • Thibaut F, Ribeyre JM, Dourmap N, Meloni R, Laurent C, et al. 1997. Association of DNA polymorphism in the first intron of the tyrosine hydroxylase gene with disturbances of the catecholaminergic system in schizophrenia. Schizophr Res 23: 259–264.

    Article  CAS  PubMed  Google Scholar 

  • Turecki G, Rouleau GA, Mari J, Joober R, Morgan K. 1997. Lack of association between bipolar disorder and tyrosine hydroxylase: A meta-analysis. Am J Med Genet 74: 348–352.

    Article  CAS  PubMed  Google Scholar 

  • Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM. 1997. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet—Neuropsychiatric Genetics 74: 439–442.

    Article  CAS  Google Scholar 

  • Versiani M, Cassano G, Perugi G, Benedetti A, Mastalli L, et al. 2002. Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. J Clin Psychiatry 63: 31–37.

    CAS  PubMed  Google Scholar 

  • Wei J, Hemmings GP. 1999. Lack of evidence for association between the COMT locus and schizophrenia. Psychiatr Genet 9: 183–186.

    Article  CAS  PubMed  Google Scholar 

  • Wei J, Ramchand CN, Hemmings GP. 1995. Association of polymorphic VNTR region in the first intron of the human TH gene with disturbances of the catecholamine pathway in schizophrenia. Psychiatr Genet 5: 83–88.

    Article  CAS  PubMed  Google Scholar 

  • Wei J, Ramchand CN, Hemmings GP. 1997. Possible association of catecholamine turnover with the polymorphic (TCAT)n repeat in the first intron of the human tyrosine hydroxylase gene. Life Sci 61: 1341–1347.

    Article  CAS  PubMed  Google Scholar 

  • Wei J, Ramchand CN, Hemmings G. 1998. TaqI polymorphic sites at the human dopamine beta-hydroxylase gene possibly associated with biochemical alterations of the catecholamine pathway in schizophrenia. Psychiatr Genet 8: 19–24.

    Article  CAS  PubMed  Google Scholar 

  • Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, et al. 2001. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50: 825–844.

    Article  CAS  PubMed  Google Scholar 

  • Weinshilboum R. 1978. Human biochemical genetics of plasma dopamine-[beta]-hydroxylase and erythrocyte catechol-O-methyltransferase. Hum Genet 45: 101–112.

    Google Scholar 

  • Wigg K, Zai G, Schachar R, Tannock R, Roberts W, et al. 2002. Attention deficit hyperactivity disorder and the gene for dopamine beta-hydroxylase. Am J Psychiatry 159: 1046–1048.

    Article  PubMed  Google Scholar 

  • Woodward D, Moises H, Waterhouse B, Yeh H, Cheun J. 1991. Modulatory actions of norepinephrine on neural circuits. Adv Exp Med Biol 287: 193–208.

    CAS  PubMed  Google Scholar 

  • Xie T, Ho SL, Li LSW, Ma OCK. 1997. G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease. Mov Disord 12: 426–427.

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto K, Cubells J, Gelernter J, Benkelfat C, Lalonde P, et al. 2003. Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: A genetic association study. Am J Med Genet 117B: 33–38.

    Article  PubMed  Google Scholar 

  • Yamamoto K, Hornykiewicz O. 2004. Proposal for a noradrenaline hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28: 913–922.

    Article  CAS  PubMed  Google Scholar 

  • Young LJ, Nilsen R, Waymire KG, Mac Gregor GR, Insel TR. 1999. Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole. Nature 400: 766–768.

    Article  CAS  PubMed  Google Scholar 

  • Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, et al. 2001. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68: 515–522.

    Article  CAS  PubMed  Google Scholar 

  • Zabetian CP, Buxbaum SG, Elston RC, Köhnke MD, Anderson GM, et al. 2003. The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine—hydroxylase activity. Am J Hum Genet 72: 1389–1400.

    Article  CAS  PubMed  Google Scholar 

  • Zhang L, Rao F, Wessel J, Kennedy BP, Rana BK, et al. 2004. Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: Prediction of catecholamines and response to stress in twins. Physiol Genomics 19: 277–291.

    Article  PubMed  CAS  Google Scholar 

  • Zhu MY, Klimek V, Dilley GE, Haycock JW, Stockmeier C, et al. 1999. Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol Psychiatry 46: 1275–1286.

    Article  CAS  PubMed  Google Scholar 

  • Zhuma T, Tyrrell R, Sekkali B, Skavdis G, Saveliev A, et al. 1999. Human HMG box transcription factor HBP1: A role in hCD2 LCR function. EMBO J 18: 6396–6406.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this entry

Cite this entry

Meloni, R. (2008). Molecular Genetics of Brain Noradrenergic Neurotransmission. In: Lajtha, A., Vizi, E.S. (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-30382-6_6

Download citation

Publish with us

Policies and ethics